Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01435265 · ClinicalTrials.gov registry record · NA
Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01435265 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 7 participants.
The verdict
NCT01435265, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a phase IV randomized, prospective open label study to asses the efficacy of an extended nurse eduction program in improving adherence to the prescribed treatment regimen in the treatment of moderate to severe psoriasis vulgaris.
Interventions
- BEHAVIORAL Standard nurse education
- BEHAVIORAL Additional nurse education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01435265
The ClinicalTrials.gov registry entry for NCT01435265 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard nurse education is the first listed.
NCT01435265 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01435265 about?
NCT01435265 is a clinical study titled "Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab". This is a phase IV randomized, prospective open label study to asses the efficacy of an extended nurse eduction program in improving adherence to the prescribed treatment regimen in the treatment of moderate to severe psoriasis vulgaris.
What is the current status of trial NCT01435265?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2010-01. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01435265?
The interventions under investigation include: Standard nurse education (BEHAVIORAL), Additional nurse education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01435265?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.